Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 3.44 USD 0.88%
Market Cap: 39.4m USD
Have any thoughts about
Collplant Biotechnologies Ltd?
Write Note

Collplant Biotechnologies Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Collplant Biotechnologies Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Additional Paid In Capital
$121.1m
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Additional Paid In Capital
$266.6m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
5%
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Additional Paid In Capital
$144.4m
CAGR 3-Years
3%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Additional Paid In Capital
$793.9m
CAGR 3-Years
19%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Additional Paid In Capital
$118m
CAGR 3-Years
4%
CAGR 5-Years
18%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Collplant Biotechnologies Ltd
Glance View

Market Cap
39.4m USD
Industry
Biotechnology

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

CLGN Intrinsic Value
15.33 USD
Undervaluation 78%
Intrinsic Value
Price

See Also

What is Collplant Biotechnologies Ltd's Additional Paid In Capital?
Additional Paid In Capital
121.1m USD

Based on the financial report for Dec 31, 2023, Collplant Biotechnologies Ltd's Additional Paid In Capital amounts to 121.1m USD.

What is Collplant Biotechnologies Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
15%

Over the last year, the Additional Paid In Capital growth was 3%. The average annual Additional Paid In Capital growth rates for Collplant Biotechnologies Ltd have been 17% over the past three years , 15% over the past five years .

Back to Top